IL1B and neoplasm: Several aspects have so far been described, such as IL-1β induced cisplatin-resistance by up-regulation of Aldo-keto reductase 1C1 [54], IL-1 dependent intra-tumoural androgen receptor signalling, T-cell attraction or stimulation and recruitment of tumour-associated fibroblasts [33].